CIPO Patents = 13

EPO Patents = 3

Trademarks = 1

Forward Citations = 21

Loading Chart...

39 inventors (with patents filed for the assignee):

Stefan Knackmuss (4 out of 15 patents)

Melvyn Little (3 out of 23 patents)

Uwe Reusch (2 out of 19 patents)

4. Karlheinz Peter (2 out of 10 patents)

5. Peter Röttgen (2 out of 6 patents)

6. Peter Roettgen (2 out of 2 patents)

7. Meike Schwarz (2 out of 2 patents)

8. Fabrice Le Gall (1 out of 8 patents)

9. Karin Hoffmann (1 out of 4 patents)

10. Sergey Kipriyanov (1 out of 5 patents)

11. Claudia Linhard (1 out of 1 patent)

12. Vera Mick (1 out of 1 patent)

13. Claudia Buettner (1 out of 1 patent)

14. Clémence Rey (1 out of 1 patent)

15. Claudia Büttner (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 8455627 - Human antibody specific for activated state of platelet integrin receptor GPIIb/IIIa (2013-06-04),

2. 7901677 - Use of an antibody against the laminin receptor or laminin receptor precursor for the treatment or diagnosis of several cancer types (2011-03-08),

3. 7812136 - Antibody of human origin specifically binding to activated state of platelet integrin receptor GPIIb/IIIa (2010-10-12),

4. 7507797 - Single-chain antibody acting against 37 kDa/67 kDa Iaminin receptor as tools for the diagnosis and therapy of prion diseases and cancer, production and use thereof (2009-03-24),

Affimed Therapeutics is a clinical-stage biopharmaceutical company focused on developing cancer immunotherapies using its innovative platform of bispecific antibodies. The company's pipeline includes both solid tumor and blood cancer candidates, with a commitment to bringing new treatment options to patients with unmet medical needs.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

4 Patents

#66 in Heidelberg

#6,923 in Germany

Heidelberg, Germany

Affimed Therapeutics, Ag

Forward Citations = 21

39 inventors:

Stefan Knackmuss (4 out of 15 patents)

Melvyn Little (3 out of 23 patents)

Uwe Reusch (2 out of 19 patents)

4. Karlheinz Peter (2 out of 10 patents)

5. Peter Röttgen (2 out of 6 patents)

Please report any incorrect information to support@idiyas.com

13 patents (CIPO):

Please report any incorrect information to support@idiyas.com

3 patents (EPO):

Please report any incorrect information to support@idiyas.com